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Down-modulation of the CD4 receptor expressed on T
cells is one of the hallmarks of Human Immunodefi-
ciency Virus (HIV) infection and it is believed to confer
to the virus a selective replicative advantage in vivo.
HIV has evolved redundant mechanisms to remove the
receptor from the cell surface and accelerate its degra-
dation. This process is mainly mediated by three viral
proteins: Vpu, Env and Nef. Up to date, the mechanisms
that lead to CD4 depletion from the surface of CD4+ T
lymphocytes, the natural targets of HIV, are still poorly
understood and only partially characterized. We are
interested in the discovery of pathways and human pro-
teins involved in the process, in order to eventually find
potential new drug targets. To pursue our aim, we first
performed a functional screening on HeLa CD4+ cells
expressing Nef, using a shRNA lentiviral interference
delivery system targeting the whole human genome
compatible with an Affymetrix GeneChip Microarray.
The read out was the rescue of the CD4 high pheno-
type, despite Nef expression. The results were analyzed
with Affymetrix Expression Console 1.1 software and
the web-based gene ontology resource DAVID. After
four different screens we obtained a final list of 75
genes enriched in the cells sorted for high surface CD4.
These genes appear to code for proteins involved in
endocytic trafficking, trans-Golgi trafficking and lysoso-
mal degradation pathways. We decided to validate our
hits in primary blood CD4+ T cells, the most relevant
for this kind of studies, and we set up a protocol for the
transduction of these cells with lentiviral and retroviral
vectors, necessary respectively for the expression of the
shRN As and the viral proteins Vpu, Nef and Env. The
actual down-regulation of the gene expression will be
validated via quantitative Real Time PCR and Western
Blot and the experiments will be eventually repeated in
the context of HIV-1 infection.
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